Discounted Cash Flow (DCF) Analysis Unlevered

NanoViricides, Inc. (NNVC)

$1.27

+0.01 (+0.79%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 1.27 | undervalue

Operating Data

Year
A/P
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue ----------
Revenue (%)
EBITDA ----------
EBITDA (%)
EBIT ----------
EBIT (%)
Depreciation ----------
Depreciation (%)

Balance Sheet Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash ----------
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable ----------
Accounts Payable (%)
Capital Expenditure ----------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 1.27
Beta 1.157
Diluted Shares Outstanding 11.53
Cost of Debt
Tax Rate 0.08
After-tax Cost of Debt 5.40%
Risk-Free Rate
Market Risk Premium
Cost of Equity 9.942
Total Debt 0.09
Total Equity 14.65
Total Capital 14.74
Debt Weighting 0.64
Equity Weighting 99.36
Wacc

Build Up Free Cash

Year
A/P
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue ----------
EBITDA ----------
EBIT ----------
Tax Rate 0.00%2.13%0.36%-0.97%0.08%0.32%0.32%0.32%0.32%0.32%
EBIAT ----------
Depreciation ----------
Accounts Receivable ----------
Inventories ----------
Accounts Payable ----------
Capital Expenditure -0.24-0.07-0.01-0.24-0.32-----
UFCF ----------
WACC
PV UFCF ----------
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 9.91
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -13.97
Equity Value -
Shares Outstanding 11.53
Equity Value Per Share -